Notably, distinct iron regulatory mechanisms have been identified in malignant cells; for instance, breast cancer cells can express hepcidin to downregulate ferroportin, thereby reducing cellular iron efflux (12). This evidence concerns the gene SLC40A1 and breast carcinoma.